Bio Rad
Bio-Rad Laboratories, Inc., a leading global provider of life science research and clinical diagnostics products, is headquartered in the United States. Founded in 1952, the company has established itself as a key player in the biotechnology industry, with significant operations across North America, Europe, and Asia. Bio-Rad's core offerings include a diverse range of products such as reagents, instruments, and software for research and clinical applications. Their innovative solutions, particularly in the fields of genomics, proteomics, and quality control, set them apart in a competitive market. Notably, Bio-Rad has achieved recognition for its commitment to advancing scientific discovery and improving healthcare outcomes. With a strong market position, Bio-Rad continues to drive progress in the life sciences sector, underscoring its role as a trusted partner for researchers and clinicians worldwide.
DitchCarbon Score
How does Bio Rad's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bio Rad's score of 28 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bio Rad's reported carbon emissions
In 2022, Bio-Rad Laboratories, Inc. reported total carbon emissions of approximately 295,930,000 kg CO2e across all scopes. This includes 21,216,000 kg CO2e from Scope 1, 16,813,000 kg CO2e from Scope 2 (market-based), and a significant 295,930,000 kg CO2e from Scope 3 emissions. The combined Scope 1 and 2 emissions totalled about 38,029,000 kg CO2e (market-based). Bio-Rad has set ambitious climate commitments, aiming to reduce its Scope 1 and 2 carbon emissions by 46% from a 2019 baseline by the year 2030. This target reflects a commitment to significant reductions in its operational carbon footprint, aligning with industry standards for sustainability and climate action. The company’s emissions data is sourced directly from Bio-Rad Laboratories, Inc., with no cascading from a parent or related organization. Bio-Rad's proactive approach to sustainability is evident in its comprehensive emissions reporting and reduction initiatives, positioning it as a responsible leader in the life sciences sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 18,420,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 13,615,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 314,454,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bio Rad is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
